TGFB1 and pulmonary fibrosis: The current study aimed to identify the influence of three representative pan-PDE inhibitors on the TGF-β-induced, pro-fibrotic phenotype of alveolar epithelial type II cells, that may contribute to the development of airway remodeling and lung fibrosis.